Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06603844
Title First-in-human Study of CRB-601-01 to Treat Patients with Advanced Solid Tumor.
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Corbus Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR


No variant requirements are available.